QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
13th Nov 2006, 19:52 GMT
QIAGEN, (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced FlexiPlate...
QIAGEN Introduces Novel Technology for Customized RNAi Assay Products related news:
- Qiagen N.V.: QIAGEN Introduces Novel Technology for Customized RNAi Assay Products — Market Wire - Pharmaceuticals and Biotech
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products — PR Newswire: All Releases
- Google introduces customized home pages for groups (Reuters) — Yahoo! News: Technology News
- Keithley Introduces PXI Products for Hybrid Test Systems in Production Applications — StratWire - Business of Healthcare NewsFeed
- Tabelle: Qiagen NV - 3. Quartal 2006 — Finanztreff.de / BRANCHEN
- SCOLR Pharma Partner Introduces 3 New Products Based on SCOLR Technology — Operations-Related News from StratCenter.com
- New Archive Attender® V 3.0 Takes Aim at Efficiency by Offering a Rapid, 15-Minute Installation — PR Leap - Technology News Releases
- QIAGEN-Zahlen treffen Erwartungen — Nachrichten Ticker - www.finanzen.net
- Qiagen erfüllt im 3Q eigene Prognose - Einmaleffekte belasten — Finanztreff.de / BRANCHEN
- Google introduces customized home pages for groups — Reuters: Internet
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL